Lisa Pagan

Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement

Michelle Mellion, Lucienne Ronco, Cécile L. Berends et al. · British Journal of Clinical Pharmacology · 2021 · 39 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +7

Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition

Jannik Rousel, Andreea Nădăban, Mahdi Saghari et al. · Experimental Dermatology · 2023 · 32 citations · Full text

Medicine, Dermatology, Immunology +17

Stereophotogrammetric three‐dimensional photography is an accurate and precise planimetric method for the clinical visualization and quantification of human papilloma virus‐induced skin lesions

M. Rijsbergen, Lisa Pagan, Tessa Niemeyer‐van der Kolk et al. · Journal of the European Academy of Dermatology and Venereology · 2019 · 13 citations · Full text

Medicine, Dermatology, Pathology +15

The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesions

Lisa Pagan, Bertine W. Huisman, Michelle van der Wurff et al. · Frontiers in Microbiology · 2023 · 13 citations · Full text

Life Sciences, Dermatology, Microbiology +15

First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring

Willem de Laat, Lisa Pagan, Karl Malcolm et al. · Drug Delivery · 2023 · 10 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13